numares Health Expands Presence in ASEAN Region
numares Health, a transformative metabolomics company, has successfully entered the ASEAN region by obtaining regulatory approval in Malaysia. This milestone marks a significant step in their mission to enhance patient care through innovative diagnostic solutions.
AXINON® LDLp Test System Receives Approval
The AXINON® LDLp Test System has received approval from the Medical Device Authority in Malaysia. This achievement underlines numares Health's commitment to bringing advanced health technology to the region. The AXINON system is designed to utilize complex biomarker analyses that guide effective treatment pathways, thereby improving the accuracy of the diagnosis.
Strategic Partnership for Distribution
To facilitate its entry into the Malaysian market, numares Health has teamed up with BioD Medica, a prominent distributor in medical devices and healthcare technology within Malaysia and Singapore. This partnership is strategic as it allows numares to leverage local expertise in navigating the regulatory landscape and healthcare needs of the region.
Innovating Patient Care Through Biomarkers
CVDs, or cardiovascular diseases, remain the leading cause of death worldwide. The AXINON® LDLp Test System shines in this scenario, as it measures lipoprotein particles, including their concentration and size, to deliver a more nuanced picture of a patient's CVD risk. Traditional lipid profile tests often fall short in capturing comprehensive data for individuals with comorbidities; however, the AXINON system fills this gap effectively.
Benefits of AXINON® Technology
The technology behind the AXINON® System not only enhances diagnostic precision but also provides actionable insights for healthcare professionals. By enabling earlier detection of complex health conditions, it supports the development of personalized treatment plans. This proactive approach marks a significant advancement over conventional diagnostic methods, particularly for those at increased risk for cardiovascular issues.
About numares Health
numares Health stands at the forefront of metabolomics, pioneering a platform that delivers critical insights into biomarkers and clinical pathways. This innovative approach focuses on utilizing NMR spectra to analyze multiple biomarkers simultaneously from a single, minimally processed sample. The goal is to streamline lab workflows while ensuring accuracy and efficiency across various healthcare settings.
The Future of Biochemical Analysis
The objective of numares Health extends beyond immediate diagnostic capabilities; they aspire to lead a significant transformation in research and treatment akin to the revolution brought about by genomic analyses in cancer care. The company aims to shift the focus from merely managing symptoms to identifying and addressing the root causes of diseases.
Frequently Asked Questions
What is the AXINON® LDLp Test System?
The AXINON® LDLp Test System measures lipoprotein particles to provide a detailed assessment of cardiovascular disease risk, improving diagnosis accuracy.
Who is BioD Medica?
BioD Medica is a distributor of medical devices and healthcare technology, specializing in the Malaysian and Singaporean markets.
How does numares Health support patient care?
numares Health utilizes advanced metabolomics solutions to deliver insights that enhance patient care through personalized treatment pathways.
What advancements does the AXINON technology bring?
The AXINON technology offers multidimensional insights for earlier detection of health issues, supporting better clinical decision-making.
What are the long-term goals of numares Health?
numares Health aims to transform medical diagnostics and treatments by focusing on uncovering underlying disease causes rather than just managing symptoms.
